Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Investors

The Company’s current investors include:

Abingworth Management
www.abingworth.com

Cancer Research Technology
www.cancertechnology.com

Essex Woodlands Healthcare Ventures
www.essexwoodlands.com

Gilde Investment Management
www.gilde.nl

GSK
www.gsk.com

Phase4 Partners
www.phase4-partners.com

The Institute of Cancer Research
www.icr.ac.uk

The University of Cambridge
www.cam.ac.uk

The Wellcome Trust
www.wellcome.ac.uk

Search
Latest News

Tosedostat Opal Study In Acute Myeloid Leukaemia Published In Lancet Oncology

Chroma Therapeutics Advances Novel Targeted Agent Towards Clinical Development; Receives Milestone Payment And Extends Collaboration With GSK

Featured Programme
Cell Accumulation Approach